Kapitalo Investimentos Ltda Seagen Inc. Transaction History

Kapitalo Investimentos Ltda

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Mar 29, 2024	SELL	$0.0 - $228.9 $0 - $16.2 Million	-70,630 Closed	0 $0
Q3 2023 Mar 29, 2024	BUY	$191.51 - $216.16 $8.56 Million - $9.66 Million	44,700 Added 172.39%	70,630 $15 Billion
Q2 2023 Mar 29, 2024	BUY	$187.64 - $206.25 $4.87 Million - $5.35 Million	25,930 New	25,930 $4.99 Billion

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.